Close



Nov 14, 2018 07:10AM
Aug 14, 2018 09:20AM
Aug 14, 2018 09:15AM
May 10, 2018 07:05AM
Mar 26, 2018 04:40PM
Nov 8, 2017 07:05AM
Sep 15, 2017 04:33PM RXI Pharma (RXII) Reports Departure of Dr. Alexey Eliseev as Chief Business Officer
Sep 15, 2017 04:30PM
Aug 10, 2017 07:05AM
May 22, 2017 07:11AM
May 22, 2017 07:05AM
May 11, 2017 07:05AM
Apr 13, 2017 08:45AM
Mar 30, 2017 07:02AM RXi Pharmaceuticals Reports Fourth Quarter and Year End 2016 Financial Results and Recent Corporate Highlights
Feb 23, 2017 09:00AM
Jan 9, 2017 07:02AM
Dec 21, 2016 09:53AM
Dec 13, 2016 07:09AM
Dec 13, 2016 07:02AM
Nov 15, 2016 09:00AM
Nov 10, 2016 07:02AM RXi Pharmaceuticals Reports Third Quarter 2016 Financial Results and Highlights Recent Corporate Developments
Oct 12, 2016 07:06AM
Oct 12, 2016 07:05AM
Oct 12, 2016 07:04AM
Oct 12, 2016 07:02AM
Aug 11, 2016 07:02AM
May 10, 2016 06:56AM
May 10, 2016 06:55AM RXi Pharmaceuticals Provides Strategic Update
Oct 20, 2015 09:28AM
May 28, 2015 09:30AM
May 27, 2015 04:11PM
May 27, 2015 04:10PM
May 13, 2015 07:05AM
Apr 17, 2015 07:51AM
Apr 17, 2015 07:50AM RXi Pharmaceuticals Receives Orphan Drug Designation for Samcyprone™ from the U.S. FDA for the Treatment of Malignant Melanoma Stage IIb to IV
Apr 14, 2015 09:27AM
Mar 30, 2015 07:02AM
Mar 27, 2015 09:04AM
Mar 27, 2015 09:03AM
Mar 27, 2015 09:02AM
Dec 22, 2014 07:06AM
Dec 19, 2014 07:07AM RXI Pharma (RXII), Hapten Pharma Enter Exclusive License for Samcypron
May 5, 2014 09:29AM
May 2, 2014 12:37PM
May 2, 2014 09:35AM

924,292 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All